Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.9K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.3K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.3K
Neuroplasticity01:01

Neuroplasticity

2.7K
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microglia-to-neuron signaling links <i>APOE4</i> and inflammation to enhanced neuronal lipid metabolism and network activity.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Protocol for generating human assembloids to investigate thalamocortical and corticothalamic synaptic transmission and plasticity.

STAR protocols·2025
Same author

Synaptic plasticity in human thalamocortical assembloids.

Cell reports·2024
Same author

Functional sensory circuits built from neurons of two species.

Cell·2024
Same author

Synaptic plasticity in human thalamocortical assembloids.

bioRxiv : the preprint server for biology·2024
Same author

Rates of contributory de novo mutation in high and low-risk autism families.

Communications biology·2021

Related Experiment Video

Updated: Apr 16, 2026

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

5.6K

Advances in reprogramming-based study of neurologic disorders.

Anjana Nityanandam1, Kristin K Baldwin1

  • 1Department of Molecular and Cellular Neuroscience, The Scripps Research Institute, La Jolla, California.

Stem Cells and Development
|March 10, 2015
PubMed
Summary

Induced pluripotent stem cells (iPSCs) offer promise for neurological disease modeling and therapy. Challenges in reproducibility and disease recapitulation remain, but advancements like 3D models and gene editing show future potential.

More Related Videos

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs
10:47

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Published on: March 2, 2018

10.7K
AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke
05:40

AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke

Published on: November 29, 2024

1.1K

Related Experiment Videos

Last Updated: Apr 16, 2026

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

5.6K
Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs
10:47

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Published on: March 2, 2018

10.7K
AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke
05:40

AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke

Published on: November 29, 2024

1.1K

Area of Science:

  • Stem cell biology
  • Neuroscience
  • Regenerative medicine

Background:

  • Recent advancements in reprogramming adult cells into neural lineages via induced pluripotent stem cells (iPSCs) and other methods.
  • Reprogramming holds significant potential for disease modeling, drug screening, cell therapy, and personalized medicine.

Purpose of the Study:

  • To review limitations in current reprogramming-based methods for disease modeling.
  • To assess progress and future prospects of reprogramming for neurological disease modeling.

Main Methods:

  • Discussion of limitations including culture heterogeneity, variability, and 2D differentiation constraints.
  • Assessment of 3D disease modeling, reprogramming technology advancements, hiPSC prescreening, and isogenic model creation using gene editing.

Main Results:

  • Human iPSC (hiPSC)-based models have demonstrated proof of principle for disease modeling.
  • Current reprogramming methods face challenges in faithfully and reproducibly recapitulating disease pathology.

Conclusions:

  • Despite challenges, reprogramming technologies are advancing for neurological disease modeling.
  • Future directions include 3D models, improved reprogramming techniques, and gene editing for precise disease modeling.